Sanofi will use AbSci’s platform to further optimize two of its in-house proteins – and will partner with other companies to accelerate timelines and reduce costs.
Pressure BioSciences has launched a commercial biopharmaceutical contract service business after acquiring a protein therapeutics platform that it says reduces challenges and manufacturing costs of the growing drug market.
eTheRNA announced it will be opening a cGMP compliant mRNA manufacturing facility in Belgium, to increase production of its three mRNA encoding proteins.
They play an important role in diseases such as diabetes and
epilepsy but until now the structure and activity of proteins found
in cell membranes have been little understood compared to proteins
dissolved within the cell's cytoplasm,...
US researchers have developed a fast and efficient, label-free
method of detecting the presence of antigens and disease
biomarkers in clinical samples.
Agilent has launched a new tool that removes the 14 most abundant
proteins found in blood plasma and serum to speed up the discovery
and identification of low-abundance proteins and biomarkers.
Researchers have provided the first online searchable
high-resolution 2D proteome of the human colon crypt to provide a
tool for other proteomics researchers looking for biomarkers and
drug targets.
Scientists have discovered that a bacteria protein secretion path,
unexploited until now, could be key in the production of
anti-infective biopharmaceuticals.
A new technology promises to speed up the categorisation of
proteins, reducing the time consuming and laborious process whilst
aiding in the detection and treatment of disease.
A current trend towards systems biology and analysis and
interactions of proteins and nucleic acids has led Qiagen to
introduce a method that reduces the complexity of proteomics
samples. Currently, researchers use primarily home...
Invitrogen subsidiary Protometrix is gearing up to launch a
microarray containing nearly all the 6,200 or so proteins in the
proteome of the yeast Saccharomyces cerevisiae, a commonly
used organism in genomics research.
Researchers in Austria have deciphered the first steps involved in
the attachment of sugar groups to proteins - a process known as
glycoslation - which could open the door to making a broad range of
human proteins in bacteria, writes...
